Profile data is unavailable for this security.
About the company
Tissue Repair Limited is an Australia-based Phase III advanced biotechnology company developing second generation wound healing agents. The Company is focused in entering Phase III clinical trials in chronic wounds for its lead drug candidate Chronic wound treatment (TR-987), with a secondary focus on commercializing Post-procedure cosmeceutical (TR Pro+) a post procedure topical gel to accelerate healing and improve skin quality following cosmetic and medical procedures. Its other applications of Glucoprime technology include the treatment of burns, an over the counter/pharmacy wound product, new bandage and scaffold products impregnated with Tissue Repair’s active pharmaceutical ingredient, veterinary products, among others.
- Revenue in AUD (TTM)3.02m
- Net income in AUD-4.24m
- Incorporated2012
- Employees--
- LocationTissue Repair LtdLevel 10, 255 Pitt StSYDNEY 2000AustraliaAUS
- Phone+61 41955-7663
- Websitehttps://tissuerepair.com.au/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anatara Lifesciences Ltd | 0.00 | -1.95m | 3.45m | -- | -- | 4.38 | -- | -- | -0.0096 | -0.0096 | 0.00 | 0.0025 | 0.00 | -- | -- | -- | -138.64 | -87.11 | -204.84 | -106.65 | -- | -- | -- | -- | -- | -- | 0.4319 | -- | -- | -- | -34.69 | -- | -- | -- |
| Acrux Ltd | 4.53m | -5.95m | 5.75m | 43.00 | -- | 5.58 | -- | 1.27 | -0.0176 | -0.0176 | 0.0129 | 0.0025 | 0.5594 | -- | 1.36 | -- | -73.45 | -48.30 | -148.89 | -61.75 | 100.00 | -- | -131.29 | -101.52 | -- | -18.59 | 0.7804 | -- | -44.08 | 3.32 | -2.50 | -- | -54.56 | -- |
| Nutritional Growth Solutions Ltd | 2.96m | -3.94m | 6.66m | -- | -- | -- | -- | 2.25 | -0.0427 | -0.0427 | 0.0318 | -0.0116 | 3.26 | 4.05 | 33.35 | -- | -433.20 | -130.49 | -- | -187.56 | 26.70 | 40.32 | -132.89 | -143.99 | 0.1206 | -19.99 | -- | -- | -16.86 | 15.95 | -0.2074 | -- | -- | -- |
| Zelira Therapeutics Ltd | 660.00 | -3.63m | 7.26m | 8.00 | -- | -- | -- | 10,995.86 | -0.3172 | -0.3172 | 0.00006 | -0.3749 | 0.0002 | 0.0102 | 0.003 | -- | -118.74 | -50.35 | -- | -56.97 | -1,236.36 | 43.05 | -583,283.30 | -2,379.12 | 0.0244 | -6.50 | -- | -- | -99.30 | -77.07 | 90.08 | -- | -- | -- |
| Immuron Ltd | 7.29m | -5.22m | 9.15m | 7.00 | -- | 0.8119 | -- | 1.26 | -0.0226 | -0.0226 | 0.0316 | 0.0345 | 0.5675 | 1.50 | 4.40 | 1,041,000.00 | -40.62 | -27.84 | -49.64 | -30.60 | 65.39 | 70.18 | -71.58 | -182.34 | 4.19 | -- | 0.00 | -- | 48.63 | 23.67 | 24.81 | -- | -- | -- |
| Tissue Repair Ltd | 3.02m | -4.24m | 10.88m | -- | -- | 0.7824 | -- | 3.61 | -0.0701 | -0.0701 | 0.0499 | 0.2301 | 0.1777 | -- | 60.84 | -- | -24.96 | -24.25 | -26.50 | -25.27 | -- | -- | -140.49 | -518.54 | 22.40 | -- | 0.00 | -- | 236.85 | -- | -2.43 | -- | -- | -- |
| Epsilon Healthcare Ltd | 6.13m | -6.12m | 11.67m | -- | -- | -- | -- | 1.90 | -0.0164 | -0.0164 | 0.0167 | -0.0097 | 0.462 | -- | 4.95 | -- | -46.14 | -33.37 | -156.14 | -46.46 | 52.23 | 49.34 | -99.85 | -136.16 | 0.3775 | -3.92 | 1.67 | -- | -15.81 | 3.16 | -403.56 | -- | -32.83 | -- |
| Calmer Co International Ltd | 8.03m | -3.99m | 13.76m | -- | -- | 7.12 | -- | 1.71 | -0.0015 | -0.0015 | 0.0029 | 0.0006 | 1.60 | 3.29 | 14.33 | -- | -79.73 | -109.82 | -171.17 | -197.50 | 42.49 | 41.18 | -49.69 | -128.71 | 1.22 | -11.32 | 0.5482 | -- | 88.48 | 59.99 | -7.13 | -- | 27.67 | -- |
| Firebrick Pharma Ltd | 293.42k | -2.63m | 15.85m | -- | -- | 9.09 | -- | 54.01 | -0.0126 | -0.0126 | 0.0014 | 0.0069 | 0.1386 | 0.8696 | 0.4855 | -- | -124.44 | -98.41 | -143.50 | -109.28 | 35.72 | -- | -897.84 | -5,384.55 | 4.75 | -- | 0.00 | -- | 1,920.80 | -- | -124.04 | -- | -- | -- |
| Oncosil Medical Ltd | 1.26m | -15.10m | 18.07m | 2.00 | -- | 3.13 | -- | 14.32 | -1.37 | -1.37 | 0.1148 | 0.217 | 0.182 | -- | 2.18 | -- | -217.79 | -97.54 | -382.54 | -117.83 | -78.62 | -54.05 | -1,196.80 | -1,258.41 | -- | -146.89 | 0.022 | -- | 116.34 | -15.15 | -26.74 | -- | -6.31 | -- |
| TrivarX Ltd | 1.13m | -943.23k | 30.00m | 4.00 | -- | 1.27 | -- | 26.48 | -0.0018 | -0.0018 | 0.0023 | 0.0204 | 0.0923 | -- | -- | -- | -7.68 | -33.47 | -8.32 | -37.46 | -- | -- | -83.27 | -373.85 | -- | -27.05 | 0.0132 | -- | 26.38 | 3.89 | 34.25 | -- | 6.29 | -- |
Data as of Feb 13 2026. Currency figures normalised to Tissue Repair Ltd's reporting currency: Australian Dollar AUD
